Financials
- Market Capitalization 6.06 M
- Employee 4
- Founded 2017
- CEO David P Luci
- Website www.acurxpharma.com
- Headquarter Delaware, United States
- FIGI BBG01184DNJ4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4870 | ADXN Addex Therapeutics Ltd - American Depositary Shares | 5.06 USD | -9.64% | -12.76% | -12.76% | -36.91% | 6.23 M USD | ||
| 4871 | PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.58 USD | -3.33% | -3.33% | -26.58% | -43.14% | 6.23 M USD | ||
| 4884 | XBIO Xenetic Biosciences, Inc. - Common Stock | 2.54 USD | -0.39% | +1.20% | -11.81% | -16.72% | 5.82 M USD | ||
| 4886 | XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 2.81 USD | -1.40% | -1.75% | +16.60% | +212.92% | 6.65 M USD |